The following Spanish stocks may be affected by newspaper reports and other factors on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:
Vidrala said on Tuesday it expected double-digit annual growth in earnings per share for the full year 2018.
Pharma Mar says gets recommendation of Independent Data Monitoring Committee (IDMC) to continue Phase III trial with Zepsyre in small-cell lung cancer.
Goldman Sachs raises to “neutral” from “sell”
Oryzon Genomics has received approval from UK’s MHRA to conduct Phiia clinical trial with Ory-2001 in patients with Alzheimer.
Bankia says has entered into an agreement with Credit Agricole for creation of a joint venture to jointly operate in consumer finance segment in Spain.
For today’s European market outlook double click on.
For real-time moves on the Spanish blue-chip index IBEX please double click on
For IBEX constituent stocks highlight .IBEX in the command box and press the F3 button on your keyboard
For latest news on Spanish stock moves double click
For Spanish language market report double click on
For latest Eurostocks report please double click on